Tirzepatide is a synthetic 39-amino-acid peptide designed as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is a high-purity research-grade compound supplied as a white lyophilized powder with purity no less than 99% by HPLC, packed in sealed serum vials for laboratory use. As a widely studied incretin-related tool, Tirzepatide is frequently applied in research on metabolic regulation, energy balance, insulin sensitivity, appetite signaling and glucose homeostasis. Investigators use it in cell-based assays, receptor pharmacology studies and preclinical metabolic models to explore combined GIP and GLP-1 pathways. The lyophilized form ensures high stability and easy reconstitution with sterile water for consistent experimental dosing. Every batch undergoes strict quality control, and a Certificate of Analysis (COA) is available for specific batches upon request to support reproducible laboratory work. For storage, keep the unopened reagent sealed at 2-8 degree C and protected from light and moisture; for long-term storage, store at -20 degree C and avoid repeated freeze-thaw cycles. We support both small trial orders and large-volume bulk orders. OEM and private-label packaging services are available for research projects, and secure neutral packing is used for all shipments with worldwide delivery to the USA, Europe, Canada, Australia, the UK and many other regions. Please note that this product is intended for laboratory research use only and is not for human or veterinary application.